MMP9 and neoplasm: In addition, co-treatment of CSRM617 and OCT attenuated the expression of ki-67 (Figure 6b) and MMP9 (Figure 6c) on tumor tissues, which indicated the significant suppression of tumor cell proliferation and invasion activity.